Skip to main content

Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Clinical Trials Using Panitumumab-IRDye800

Review the clinical trials studying panitumumab-irdye800 on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.

You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.

Trials 1-5 of 5

An Imaging Agent (Panitumumab-IRDye800) for the Detection of Head and Neck Cancer During Surgery
Status: Active
Location: University of Alabama at Birmingham Cancer Center, Birmingham, Alabama
Panitumumab-IRDye800 in Detecting Cancer in Participants with Lung Cancer During Surgery
Status: Active
Location: Stanford Cancer Institute Palo Alto, Palo Alto, California
Panitumumab-IRDye800 in Diagnosing Participants with Malignant Glioma Undergoing Surgery
Status: Active
Location: 2 locations
Panitumumab-IRDye800 in Finding Cancer in Patients with Pancreatic Cancer Undergoing Surgery
Status: Active
Location: Stanford Cancer Institute Palo Alto, Palo Alto, California
Evaluating the Use of Dual Imaging Techniques for Detection of Disease in Patients with Head and Neck Cancer
Status: Active
Location: Vanderbilt University/Ingram Cancer Center, Nashville, Tennessee